This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

First Postoperative Day Review After Uneventful Phacoemulsification

This study has been completed.
Information provided by:
Veroia General Hospital Identifier:
First received: November 23, 2010
Last updated: NA
Last verified: April 2009
History: No changes posted
The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.

Phacoemulsification Complications BCVA

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Further study details as provided by Veroia General Hospital:

Primary Outcome Measures:
  • Best corrected visual acuity

first day review
non-first day review


Ages Eligible for Study:   65 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
291 consecutive patients who underwent uneventful phacoemulsification cataract surgery were randomized into two groups: i) Next day review (NDR group, n=146) and ii) No next day review (NNDR group, n=145).

Inclusion Criteria:

Exclusion Criteria:

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01247155

General Hospital of Veroia
Veroia, Imathia, Greece, 59100
Sponsors and Collaborators
Veroia General Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT01247155     History of Changes
Other Study ID Numbers: 9151
Study First Received: November 23, 2010
Last Updated: November 23, 2010 processed this record on September 19, 2017